Anika Therapeutics (ANIK) Current Deferred Tax Assets (2010 - 2015)

Anika Therapeutics (ANIK) has 6 years of Current Deferred Tax Assets data on file, last reported at $1.4 million in Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $1.4 million, up 113.85% year-over-year; the trailing twelve-month figure through Sep 2015 was $1.4 million (up 113.85% YoY), and the FY2014 annual result was $1.2 million, up 80.38% from the prior year.
• Current Deferred Tax Assets retreated to $1.4 million in Q3 2015 per ANIK's latest filing, from $1.5 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $2.0 million in Q4 2012 and troughed at $659040.0 in Q4 2013.
• A 5-year average of $1.5 million and a median of $1.9 million in 2011 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2013 and 2015: Current Deferred Tax Assets slumped 67.56% in 2013, then jumped 125.76% in 2015.
• A 5-year view of Current Deferred Tax Assets shows it stood at $1.9 million in 2011, then grew by 5.87% to $2.0 million in 2012, then tumbled by 67.56% to $659040.0 in 2013, then surged by 80.38% to $1.2 million in 2014, then rose by 18.55% to $1.4 million in 2015.
• Business Quant data shows ANIK's Current Deferred Tax Assets at $1.4 million in Q3 2015, $1.5 million in Q2 2015, and $1.5 million in Q1 2015.